MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)

CUSIP: 55279B202

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.00000002 par value
Shares outstanding
29,545,622
Total 13F shares
56,055,550
Share change
-32,768,050
Total reported value
$33,769,440
Put/Call ratio
19%
Price per share
$0.60
Number of holders
85
Value change
-$85,348,603
Number of buys
48
Number of sells
55

Security key

55279B202

Report period

Q1 2022

Institutions

85

Top holders

10

Top shareholders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MPM BioImpact LLC
13F
Company
42%
12,350,971
$32,977,000 31 Dec 2021
13F
First Light Asset Management, LLC
13F
Company
38%
11,217,426
$29,951,000 31 Dec 2021
13F
WASATCH ADVISORS LP
13F
Company
32%
9,342,310
$24,944,000 31 Dec 2021
13F
NEA Management Company, LLC
13F
Company
29%
8,533,072
$22,783,000 31 Dec 2021
13F
BlackRock Finance, Inc.
13F
Company
23%
6,689,871
$17,861,000 31 Dec 2021
13F
VANGUARD GROUP INC
13F
Company
20%
5,769,739
$15,405,000 31 Dec 2021
13F
BVF INC/IL
13F
Company
12%
3,532,057
$9,431,000 31 Dec 2021
13F
Boxer Capital, LLC
13F
Company
9.9%
2,913,091
$7,778,000 31 Dec 2021
13F
Point72 Asset Management, L.P.
13F
Company
9.5%
2,800,500
$7,477,000 31 Dec 2021
13F
Anson Funds Management LP
13F
Company
9.5%
2,796,510
$7,467,000 31 Dec 2021
13F
STATE STREET CORP
13F
Company
6.4%
1,887,174
$5,039,000 31 Dec 2021
13F
DAFNA Capital Management LLC
13F
Company
6%
1,764,846
$4,712,000 31 Dec 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
5.8%
1,724,630
$4,604,000 31 Dec 2021
13F
Woodline Partners LP
13F
Company
5.1%
1,508,520
$4,028,000 31 Dec 2021
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
4.8%
1,412,067
$3,770,000 31 Dec 2021
13F
Opaleye Management Inc.
13F
Company
4.5%
1,315,000
$3,511,000 31 Dec 2021
13F
CITADEL ADVISORS LLC
13F
Company
3.5%
1,039,191
$2,775,000 31 Dec 2021
13F
Artal Group S.A.
13F
Company
3.4%
1,000,000
$2,670,000 31 Dec 2021
13F
NORTHERN TRUST CORP
13F
Company
3.4%
990,614
$2,645,000 31 Dec 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.9%
866,786
$2,314,000 31 Dec 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
2.8%
815,029
$2,177,000 31 Dec 2021
13F
Velan Capital Investment Management LP
13F
Company
2.5%
747,768
$1,997,000 31 Dec 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
2.3%
687,290
$1,836,000 31 Dec 2021
13F
MACQUARIE GROUP LTD
13F
Company
2%
600,000
$1,602,000 31 Dec 2021
13F
Sio Capital Management, LLC
13F
Company
1.4%
426,047
$1,138,000 31 Dec 2021
13F
Brandywine Global Investment Management, LLC
13F
Company
1.4%
419,800
$1,121,000 31 Dec 2021
13F
Bank of New York Mellon Corp
13F
Company
1.2%
362,831
$969,000 31 Dec 2021
13F
Nuveen Asset Management, LLC
13F
Company
1.2%
357,643
$835,000 31 Dec 2021
13F
Schonfeld Strategic Advisors LLC
13F
Company
1.1%
338,635
$903,000 31 Dec 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.99%
293,437
$784,000 31 Dec 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.94%
277,987
$742,000 31 Dec 2021
13F
MARSHALL WACE, LLP
13F
Company
0.9%
266,579
$712,000 31 Dec 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.79%
234,776
$627,000 31 Dec 2021
13F
ClariVest Asset Management LLC
13F
Company
0.79%
233,800
$624,000 31 Dec 2021
13F
Carlson Capital, L.P.
13F
Company
0.64%
190,000
$507,000 31 Dec 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.59%
172,904
$462,000 31 Dec 2021
13F
Sigma Planning Corp
13F
Company
0.54%
158,350
$423,000 31 Dec 2021
13F
ALPS ADVISORS INC
13F
Company
0.51%
150,655
$402,000 31 Dec 2021
13F
Investmark Advisory Group LLC
13F
Company
0.46%
136,000
$363,000 31 Dec 2021
13F
BARCLAYS PLC
13F
Company
0.45%
131,587
$351,000 31 Dec 2021
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.41%
119,674
$320,000 31 Dec 2021
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.4%
116,833
$311,000 31 Dec 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.37%
110,308
$294,000 31 Dec 2021
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.36%
107,052
$286,000 31 Dec 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.34%
100,900
$269,000 31 Dec 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.34%
99,654
$266,000 31 Dec 2021
13F
EMC Capital Management
13F
Company
0.32%
95,372
$255,000 31 Dec 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.32%
93,323
$249,000 31 Dec 2021
13F
MORGAN STANLEY
13F
Company
0.31%
90,482
$242,000 31 Dec 2021
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.28%
83,650
$223,000 31 Dec 2021
13F

Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q1 2022

As of 31 Mar 2022, MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,055,550 shares. The largest 10 holders included NEA Management Company, LLC, BlackRock Inc., VANGUARD GROUP INC, First Light Asset Management, LLC, BVF INC/IL, Anson Funds Management LP, BOXER CAPITAL, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and DAFNA Capital Management LLC. This page lists 85 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
104
Q1 2022 holders
85
Holder diff
-19
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .